Kevin M Biglan
Overview
Explore the profile of Kevin M Biglan including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
51
Citations
1574
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
11.
Biglan K, Oakes D, Lang A, Hauser R, Hodgeman K, Greco B, et al.
Ann Clin Transl Neurol
. 2017 Jun;
4(6):360-368.
PMID: 28589163
Objective: To describe the rationale for a novel study design and baseline characteristics of a disease-modifying trial of isradipine 10 mg daily in early Parkinson disease (PD). Methods: STEADY-PDIII is...
12.
Schneider R, Biglan K
Lancet Neurol
. 2017 Jun;
16(7):541-551.
PMID: 28566190
Disparities in access to health care, particularly specialist care, exist worldwide. As the prevalence of chronic neurological disorders increases with ageing populations, access to neurologist care is likely to worsen...
13.
Tarolli C, Chesire A, Biglan K
Tremor Other Hyperkinet Mov (N Y)
. 2017 Apr;
7:454.
PMID: 28428907
Background: Huntington disease is a fatal, autosomal dominant, neurodegenerative disorder manifest by the triad of a movement disorder, behavioral disturbances, and dementia. At present, no curative or disease modifying therapies...
14.
Ray Dorsey E, Vlaanderen F, Engelen L, Kieburtz K, Zhu W, Biglan K, et al.
Mov Disord
. 2016 Aug;
31(9):1258-62.
PMID: 27501323
In many ways, the care of individuals with Parkinson disease does not meet their needs. Despite the documented benefits of receiving care from clinicians with Parkinson disease expertise, many patients...
15.
Andrzejewski K, Dowling A, Stamler D, Felong T, Harris D, Wong C, et al.
J Huntingtons Dis
. 2016 Jun;
5(2):199-206.
PMID: 27341134
Background: The Unified Huntington's Disease Rating Scale (UHDRS) is the principal means of assessing motor impairment in Huntington disease but is subjective and generally limited to in-clinic assessments. Objective: To...
16.
Ray Dorsey E, Achey M, Beck C, Beran D, Biglan K, Boyd C, et al.
Telemed J E Health
. 2016 Feb;
22(7):590-8.
PMID: 26886406
Background: Delivering specialty care remotely directly into people's homes can enhance access for and improve the healthcare of individuals with chronic conditions. However, evidence supporting this approach is limited. Materials...
17.
Achey M, Beck C, Beran D, Boyd C, Schmidt P, Willis A, et al.
Trials
. 2016 Jan;
17:7.
PMID: 26733455
No abstract available.
18.
Ray Dorsey E, Wagner J, Bull M, Rizzieri A, Grischkan J, Achey M, et al.
J Parkinsons Dis
. 2015 Sep;
5(3):505-15.
PMID: 26406130
Background: Fox Trial Finder is an online registry for individuals with and without Parkinson disease (PD) interested in participating in PD research. However, distance or disability could prevent such individuals...
19.
Achey M, Beck C, Beran D, Boyd C, Schmidt P, Willis A, et al.
Trials
. 2014 Nov;
15:465.
PMID: 25431346
Background: Interest in improving care for the growing number of individuals with chronic conditions is rising. However, access to care is limited by distance, disability, and distribution of doctors. Small-scale...
20.
Abdolahi A, Bull M, Darwin K, Venkataraman V, Grana M, Ray Dorsey E, et al.
Health Informatics J
. 2014 Nov;
22(2):304-11.
PMID: 25391849
Remote assessments of individuals with a neurological disease via telemedicine have the potential to reduce some of the burdens associated with clinical care and research participation. We aim to evaluate...